Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Liabilities and Shareholders Equity (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $122.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 4.97% to $122.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $495.4 million, a 3.41% increase, with the full-year FY2025 number at $124.2 million, up 5.15% from a year prior.
  • Liabilities and Shareholders Equity was $122.0 million for Q4 2025 at Aytu Biopharma, down from $125.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $265.7 million in Q2 2021 to a low of $115.8 million in Q3 2024.
  • A 5-year average of $149.3 million and a median of $132.9 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 73.31% in 2021, then plummeted 48.2% in 2022.
  • Aytu Biopharma's Liabilities and Shareholders Equity stood at $223.8 million in 2021, then plummeted by 36.81% to $141.4 million in 2022, then fell by 7.2% to $131.2 million in 2023, then dropped by 11.45% to $116.2 million in 2024, then increased by 4.97% to $122.0 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Liabilities and Shareholders Equity are $122.0 million (Q4 2025), $125.0 million (Q3 2025), and $124.2 million (Q2 2025).